Trisomy 21 or Down's syndrome (DS) is the most common genetic cause of human mental retardation and occurs with a prevalence of 1 in 600-1000 live births. It stems from the failure of chromosome 21 to segregate normally during meiosis (Lejeune et al. 1959) . Despite substantial research, the cause of chromosome non-disjunction leading to trisomy 21 remains unclear. Abnormal folate metabolism and a common polymorphism in the folate metabolism gene have been described as possible causes of DS (James et al. 1999) . A deficiency in cellular folate and methyl donors have been associated with abnormal DNA methylation, DNA strand breaks and abnormal chromosome segregation (James & Hobbs, 2002) . Although some studies have confirmed an association of certain polymorphisms in genes encoding enzymes of folate metabolism (Hobbs et al. 2000; O'Leary et al. 2002; Grillo et al. 2002; Bosco et al. 2003; da Silva et al. 2005) , other studies performed in different ethnic populations have shown inconsistent results (ChadefauxVekemans et al. 2002; Stuppia et al. 2002; Sheth & Sheth, 2003; Boduroglu et al. 2004) .
Since the enzyme 5,10-methylenetetrahydrofolate reductase (MTHFR) acts at the critical metabolic juncture in the folate and homocysteine metabolism, it is interesting to extend studies to known common polymorphisms in other candidate genes encoding proteins that are involved in the folate and homocysteine pathway. We analysed the relationship between MTHFR-677C . T, MTHFR-1298A . C, methionine synthase (MTR) 2756A . G, methionine synthase reductase (MTRR) 66A . G, cystathionine b-synthase (CBS) 844ins68 and reduced folate carrier (RFC-1) 80G . A common polymorphisms and trisomy 21 in the French population, as well as evaluating the possibility of interaction between these genes. We hypothesised that common polymorphisms in key genes involved in folate metabolism may be risk factors for trisomy 21 in some but not all populations. Inconsistencies between studies may be due to genetic heterogeneity between populations.
Subjects and methods
Participants were either Caucasian mothers of individuals with full trisomy 21 confirmed by karyotype or mothers of normal healthy unrelated subjects. All trisomy were diagnosed as maternally derived and occurred in meiosis I. One hundred and nineteen unselected mothers of individuals with trisomy 21 (case mothers) and 119 control mothers were matched for age. Control mothers were enrolled providing that they had not given birth to children with any congenital abnormality (trisomy, neural-tube defect, heart defect, autism and others). Medical records held information about maternal age, pregnancy outcome, previous abortions, miscarriages and number of normal childbirths. The study protocol was approved by the Ethical Committee for Studies on humans at the University Hospital Centre in Nancy, France, and written informed consent was obtained from the participants.
Human genomic DNA was isolated from peripheral blood samples with NucleoSpin Blood Quick Pure (Machery-Nagel, Cergy Pontoise, France). The 677C . T MTHFR variant was identified using PCR followed by restriction enzyme digestion of the amplified product (Frosst et al. 1995) . The MTHFR 1298 A . C was measured using the technique described by van der Put et al. (1998) . The common MTR polymorphism that causes an A . G transition at 2756 bp, converting an aspartic acid (D-919) into glycine, was identified according to the method of van der Put et al. (1997) . The MTRR A . G transition at 66 bp that converts an isoleucine into a methionine residue was identified using a modified method of Wilson et al. (1999) . The common CBS polymorphism that causes an insertion of 68 bp at the 844 position was identified using the method of Tsai et al. (1996) . The RFC 80 G . A polymorphism was identified as described elsewhere using the restriction enzyme Cfo I (Chango et al. 2000a) .
Differences in allele frequencies and genotype distribution among the different groups were assessed by the x 2 test. A Fisher -Freeman -Halton exact test replaced the x 2 test when at least one expected value was , 5. A P value ,0·05 was considered statistically significant.
Results
The age of case mothers when giving birth to babies with DS was 33·8 (SD 6) years compared with 29·5 (SD 6) years for control mothers. The characteristics of case mothers and controls are given in Table 1 for precedent abortions, miscarriages or number of childbirths. Numbers of case mothers and control mothers grouped by gene genotypes are shown in Table 2 . No evidence was found for association between studied polymorphisms and the occurrence of trisomy 21. Concerning the frequency of the MTHFR 677 variant T, 37 % of allele frequency in case mothers were not significantly higher than the frequency in control mothers (34·4 %). For the MTRR variant G allele, the frequency was 68 % in case mothers compared with 65 % in control mothers. Analysis of RFC 80G . A polymorphism showed no significant difference for the normal allele G between case mothers (52·1 %) and control mothers (55·8 %). The effect of combined genotypes on DS risk was tested by analysing joint distribution of both loci MTHFR 677CT þ TT and other genotypes. As shown in Table 3 , there was not any significant association between combined MTHFR 677C . T and other genotypes. A study of the combination of the presence of allele T (MTHFR 677) with the alleles of the four other genes gave similar results and no significant effect. Regarding genotype frequency, the number of individuals with both loci MTHFR 677CT þ TT homozygous RFC-1 80AA was higher among case mothers (23·5 %) than control mothers (11·3 %) although this did not reach statistical significance. The association MTR/MTTR showed no significant difference between case mothers and control mothers.
Discussion
Chromosomal non-disjunction is a rare adverse event that occurs during oocyte maturation (meiosis I) or at the time of conception (meiosis II) (McKim & Hawley, 1995; Lamb et al. 1997) . To date, advanced age is the only well-established risk factor. The study by James et al. (1999) was the first to suggest an association between abnormal folate metabolism and the occurrence of trisomy 21-affected pregnancies in a sample of young mothers. Folate and homocysteine metabolism can be influenced by genetic variants in MTHFR, MTR and MTRR; however, nutritional deficiencies in folic acid or vitamin B 12 are often necessary to detect phenotypic expression of these gene variants (Bailey & Gregory, 1999; Christensen et al. 1999) . Common polymorphisms in these genes have been found in some cases to be associated with elevated levels of plasma homocysteine. Concerning MTHFR 677C . T polymorphism, the present results in this French population are in accordance with previous studies conducted by Chadefaux-Vekemans et al. (2002) . In their study, mothers did not show a correlation between TT and homocysteine, suggesting that folate intake in France may nullify any effect of the MTHFR TT polymorphism (Chango et al. 2000b) . Similar results have also been found in an Italian study conducted by Bosco et al. (2003) . Both studies suggested that the Mediterranean diet high in folate could nullify a possible effect of MTHFR polymorphism on DS risk. These results are also consistent with the low frequency of neural-tube defects in both countries (James, 2004) .
Polymorphisms in CBS and RFC-1 are known to influence folate and homocysteine metabolism. The present study is the first to analyse RFC-1 common polymorphisms in the risk of having an offspring with trisomy 21. CBS Ins þ allelic variant frequency was not significantly different in both groups, even when combined with MTHFR677C . T polymorphism. However, the present study did show a trend toward an increase in the frequency of the combined homozygote RFC-1 80AA with MTHFR 677 variant T allele (677-(CT þ TT)) in DS mothers (23·5 %) compared with control mothers (11·3 %). Among participants of our previous random study (Chango et al. 2000a) , homozygous RFC-1 genotypes were 21·9 % 80AA and 27·2 % 80GG. Homozygous RFC-1 80AA and MTHFR 677TT had lower erythrocyte folate level than homozygous MTHFR 677TT alone or combined homozygous RFC-1 80AA and MTHFR 677CC. Morin et al. (2003) have recently shown that the combination of RFC-1 80G . A polymorphism and low erythrocyte folate was due to a significant 4·6-fold increase in spina bifida. It is interesting to note the hypothesis that, in some genetic determinants of folate metabolism, a common pathway may exist for neural tube defects and trisomy 21 (Al-Gazali et al. 2001; Barkai et al. 2003; Guéant et al. 2003) . Based on evidence that abnormal one-carbon metabolism can lead to abnormal chromosomal segregation, Bosco et al. (2003) observed high levels of plasma total homocysteine in mothers with polymorphism in MTHFR 677C . T and MTRR 66A . G genes. This was found to be associated with an increased risk of having a child with trisomy 21. In the present study, because blood samples were not available at the birth of trisomy 21 individuals, blood folate or homocysteine was not taken into account. One of the major unanswered issues we must address concerning folate deficiency and chromosome hypomethylation in non-disjunction is the role of homocysteine during meisis I (or meiosis II) stages. Case mothers in the present study were aged from 18 to 46 years (mean 33·8 (SD 6) years) at the time of DS pregnancy outcome. Homocysteine increased secondary to folate might accelerate age-related phenomena causing the delivery of abnormal oocytes, particularly among mothers under 35 years. The diagnosis of specific genotypes in terms of specific metabolic biomarkers such as blood folate and/ or homocysteine would increase the sensitivity to detect an impact of genotype on the risk of having a trisomy 21 child.
In conclusion, we did not find an association between studied single gene polymorphisms and the occurrence of trisomy 21. A limitation of the present study is the absence of homocysteine and erythrocyte folate data, to increase the sensitivity to detect a correlation between genotype and risk of trisomy 21.
